Partial measures compromise effectiveness of efforts to combat COVID-19
Abbreviated coronavirus dashboard for May 19: testing improvement continues
Fight COVID-19 Deaths With Personal Responsibility
Macro Briefing | 18 May 2020
Weekly Market Review: Despite Negative Data, Some Stocks Rally
Massive Loss Expected For US Q2 GDP
COVID-19 much more fatal for men, especially taking age into account
Skilled partners in the conduct of HIV prevention trials join COVID-19 response
Coronavirus Shakes Markets—Likely Temporarily
COVID-19 Leads to Dispersion in EM Debt
Coronavirus – weekly update – 13 May 2020
Coronavirus – weekly update – 11 May 2020
Biotech’s Golden Moment
Coronavirus dashboard: updating the 52 Petri Dishes of democracy
Merck CPO Julie Gerberding On The Deadliness Of Covid-19
2 Cruise Line Stocks to Bet on After the Coronavirus Crisis (And 1 to Avoid)
Free trade now: A case for tariff reductions and non-tariff measures simplifications to fight COVID-19 (coronavirus)
Macro Briefing | 11 May 2020
There is no magic bullet
Coronavirus dashboard for May 10: testing continues to improve, major differences between NYC metro and rest of US
Weekly Market Review: Stocks Back to Winning Ways
What would it take to deploy COVID-19 vaccines through sustainable cold chains?
Markets, the economy and the virus
When Will The US Coronavirus Recession Peak?
BioNTech (BNTX) Stock Could Stay Grounded... For Now
Mid-Market Update: Stocks steady, Yen rallies on data, Oil win streak snapped, Deficits drive yields higher, Gold softens, LATAM in focus
COVID-19 – six signposts to assess the market [infographic]
Can The Stock Market’s ‘V’ Recovery Survive Economic Collapse?
Realistic Cost-Benefit Analysis Yields Controversial Results
Macro Briefing | 5 May 2020